Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Operating activities
Net earnings (loss)	$ 447	$ 541	[1]
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities
Other charges (gains), net of amounts used	(8)	(13)
Depreciation, amortization and accretion	238	236
Pension and postretirement benefit expense	(16)	7	[1]
Pension and postretirement contributions	(49)	(151)	[1]
Deferred income taxes, net	7	(87)	[1]
(Gain) loss on disposition of businesses and assets, net	2	2
Debt Issuance cost	1	0
Other, net	(23)	85
Operating cash provided by (used in) discontinued operations	(5)	0
Changes in operating assets and liabilities
Trade receivables - third party and affiliates, net	(113)	(62)
Inventories	(34)	1
Other assets	(82)	15
Trade payables - third party and affiliates	100	58
Other liabilities	143	29	[1]
Net cash provided by (used in) operating activities	608	661
Investing activities
Capital expenditures on property, plant and equipment	(259)	(270)
Acquisitions, net of cash acquired	0	(23)
Proceeds from sale of businesses and assets, net	13	1
Capital expenditures related to Kelsterbach plant relocation	(6)	(43)
Other, net	(38)	(62)
Net cash provided by (used in) investing activities	(290)	(397)
Financing activities
Short-term borrowings (repayments), net	(12)	(7)
Proceeds from short-term debt	154	50
Repayments of short-term debt	(51)	(50)
Proceeds from long-term debt	74	0
Repayments of long-term debt	(192)	(32)
Refinancing costs	(2)	0
Purchases of treasury stock, including related fees	(102)	(37)
Stock option exercises	3	58
Series A common stock dividends	(55)	(31)
Other, net	0	28
Net cash provided by (used in) financing activities	(183)	(21)
Exchange rate effects on cash and cash equivalents	6	3
Net increase (decrease) in cash and cash equivalents	141	246
Cash and cash equivalents as of beginning of period	959	682
Cash and cash equivalents as of end of period	$ 1,100	$ 928

[1] As Adjusted (Note 1)